| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |